Live-attenuated Chikungunya vaccine: a possible new era

被引：0
|
作者：
Stephenson, Kathryn E. [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA
来源：
LANCET | 2023年 / 401卷 / 10394期
关键词：
VIRUS;
D O I：
10.1016/S0140-6736(23)01170-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2090 / 2091
页数：2
相关论文
共 50 条
  • [41] Characterization of a live-attenuated HCMV-based vaccine platform
    Patrizia Caposio
    Sjoerd van den Worm
    Lindsey Crawford
    Wilma Perez
    Craig Kreklywich
    Roxanne M. Gilbride
    Colette M. Hughes
    Abigail B. Ventura
    Robert Ratts
    Emily E. Marshall
    Daniel Malouli
    Michael K. Axthelm
    Daniel Streblow
    Jay A. Nelson
    Louis J. Picker
    Scott G. Hansen
    Klaus Früh
    Scientific Reports, 9
  • [42] A Bivalent Live-Attenuated Vaccine for the Prevention of Equine Influenza Virus
    Blanco-Lobo, Pilar
    Rodriguez, Laura
    Reedy, Stephanie
    Oladunni, Fatai S.
    Nogales, Aitor
    Murcia, Pablo R.
    Chambers, Thomas M.
    Martinez-Sobrido, Luis
    VIRUSES-BASEL, 2019, 11 (10):
  • [43] Humanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises
    O'Connell, Aoife K.
    Douam, Florian
    VACCINES, 2020, 8 (01)
  • [44] Engineering a new vaccine platform for heterologous antigen delivery in live-attenuated Mycobacterium tuberculosis
    Broset, Esther
    Calvet Seral, Juan
    Arnal, Carmen
    Uranga, Santiago
    Kanno, Alex, I
    Leite, Luciana C. C.
    Martin, Carlos
    Gonzalo-Asensio, Jesus
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 4273 - 4283
  • [45] Reverse genetic platform for inactivated and live-attenuated influenza vaccine
    Eun-Ju Jung
    Kwang-Hee Lee
    Baik Lin Seong
    Experimental & Molecular Medicine, 2010, 42 : 116 - 121
  • [46] Reverse genetic platform for inactivated and live-attenuated influenza vaccine
    Jung, Eun-Ju
    Lee, Kwang-Hee
    Seong, Baik Lin
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2010, 42 (02): : 116 - 121
  • [47] Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design
    VanBuskirk, Kelley M.
    O'Neill, Matthew T.
    De la Vega, Patricia
    Maier, Alexander G.
    Krzych, Urszula
    Williams, Jack
    Dowler, Megan G.
    Sacci, John B., Jr.
    Kangwanrangsan, Niwat
    Tsuboi, Takafumi
    Kneteman, Norman M.
    Heppner, Donald G., Jr.
    Murdock, Brant A.
    Mikolajczak, Sebastian A.
    Aly, Ahmed S. I.
    Cowman, Alan F.
    Kappe, Stefan H. I.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (31) : 13004 - 13009
  • [48] Characterization of a live-attenuated HCMV-based vaccine platform
    Caposio, Patrizia
    van den Worm, Sjoerd
    Crawford, Lindsey
    Perez, Wilma
    Kreklywich, Craig
    Gilbride, Roxanne M.
    Hughes, Colette M.
    Ventura, Abigail B.
    Ratts, Robert
    Marshall, Emily E.
    Malouli, Daniel
    Axthelm, Michael K.
    Streblow, Daniel
    Nelson, Jay A.
    Picker, Louis J.
    Hansen, Scott G.
    Fruh, Klaus
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [49] Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery
    Lin, Ivan Y. C.
    Thi Thu Hao Van
    Smooker, Peter M.
    VACCINES, 2015, 3 (04) : 940 - 972
  • [50] First-in-human trial of a live-attenuated Mycobacterium tuberculosis vaccine
    Geldmacher, Christof
    Hatherill, Mark
    LANCET RESPIRATORY MEDICINE, 2015, 3 (12): : 906 - 907
12345